SlideShare ist ein Scribd-Unternehmen logo
1 von 22
Rebecca Ruggear
Thursday, April 4, 2013
PB 449 Senior Seminar Oral Defense of Thesis
Thesis Statement
• In order to affect better patient
outcomes, the burden of adherence
needs to shift away from solely the
patient to other stakeholders such as
physicians and pharmacists.
What is adherence?
• Adherence is “the extent to which a person’s behavior –
taking medication, following a diet, and/or executing
lifestyle changes, corresponds with agreed
recommendations from a health care provider.”1,2
• The reason this responsibility is left to the patients is
because, “it’s easier to blame patients and hold onto the
simplistic view that cost is the key drive, rather than to
understand the underlying symptoms that can lead to the
right interventions at the right time to increase
adherence.”6
1. Haynes, RB. (1979). Determinants of compliance: The disease and the mechanics of treatment. Baltimore MD,
Johns Hopkins University Press.
2. Rand, CS. (1993). Measuring adherence with therapy for chronic disease: implications for the treatment of
heterozygous familial hypercholesterolemia. American Journal of Cardiology, 72:68D-74D.
Another look at responsibility
• ”A significant barrier to effective medical treatment is
the patient's failure to follow the recommendations of
his or her physician or other healthcare provider.”12
• “Patients' health literacy is central to their ability to
adhere. ”12
12. . Martin, L., et al. (1 September, 2005). The Challenge of Patient Adherence; 1(3): 189–199. Clinical Risk
Management. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1661624/citedby/.
Why are patients non-adherent?
• The five main reasons for non-adherence include9:
– Negative side effects
– Perceived under-performance of the product
– Complexity of the treatment regime
– No improvement noticed by patient
– Cost
9. Forissier, T. (April 2012). Patient Adherence: Initiating the Journey, 2(4), 26-28.
Does adherence matter?
Express Scripts Drug Trend Report. (2011). Nonadherence: New Insights. Retrieved February 26th,
2013, from http://www.drugtrendreport.com/insights-and-solutions/nonadherence-new-
insights/more-than-patient-education.
What are the numbers?
• Adherence to long-term therapy for chronic illnesses in
developed countries averages 50%.1,5
– Rates are even lower in developing countries.
• Non-adherence costs the U.S. health care system
between $100 billion and $289 billion annually.11
• Estimates of hospitalization costs due to medication non-
adherence are as high as $13.35 billion annually in the
US alone.11
1.Haynes, RB et al. (2001). Interventions for helping patients to follow prescriptions for medications. Cochrane
Database of Systematic Reviews, Issue
5. Sacket, D. et al. (1978). Patient compliance with antihypertensive regimens. Patient Counselling & Health
Education, 11:18-21.
11. Viswanathan, M. et al. (December 2012). Interventions to Improve Adherence to Self-administered Medications for
Chronic Diseases in the United States: A Systematic Review. Annals of Internal Medicine.;157(11):785-795.
How does being adherent save
money?
• Higher rates of adherence contribute to economic
benefits8
– “Direct savings caused by reduced use of sophisticated and
expensive health services needed in cases of disease
exacerbation, crisis or relapse.”8
– “Indirect savings may be attributable to enhancement or
preservation of, quality of life and the social and vocational
roles of the patients.”8
– Reduction in the numbers of patients being hospitalized,
days in the hospital and outpatient visits.7
• Cost to savings ratio of approx. 1:10 over a 3 year study
7. Sloss, EM et al. (2000). Selecting target conditions for quality of care improvement in vulnerable older
adults. Journal of the American Geriatrics Society, 48:363-369.
8. World Health Organization. (2003). Adherence to long-term therapies: evidence for action. WHO
publications.
Specific savings
• Pharmacy costs for all
prescriptions filled, ranged
from $2,867 to $3,780 per
patient per year.10
• Annual medical spending
was significantly lower for
adherent patients.
• Savings are mainly through
reduced inpatient hospital
days and emergency
department visits.
10. Roebuck, M. C., Liberman, J. N., Gemmill-
Toyama, M., & Brennan, T. A. (2011). Medication
adherence leads to lower health care use and costs
despite increased drug spending. Health
Affairs, 30(1), 91-9. Retrieved from
http://search.proquest.com/docview/847269644?acc
ountid=29001
Disease
state
Total
health
care
costs
Average
annual
medical
spending
Annual
per
person
savings
Congestive
heart failure
$39,076 $8,881 $7,823
Hypertension $14,813 $4,337 $3,908
Diabetes $17,955 $4,413 $3,756
Dyslipidemia $12,688 $1,860 $1,258
Positive impact on patient health
“Increasing the effectiveness of adherence interventions
may have a far greater impact on the health of the
population than any improvement in specific medical
treatments.”3
3. Haynes, RB et al. (2001). Interventions for helping patients to follow prescriptions for medications. Cochrane Database
of Systematic Reviews, Issue 1.
Tackling The Problem
• Objectives
– Determine general attitudes on whose responsibility it is for
patient adherence.
– Determine reasons for non-adherent behavior.
– Research tactics and effectiveness of those tactics to
increase patient adherence.
• Subjects
– Healthcare Professionals
• Pharmacists
• General Practitioners
• Specialist Physicians
• Nurses/Physician Assistants
– Patients (M/W aged 30+)
Where do we find them?
• Healthcare professionals
• Web-based survey (Surveymonkey.com)
– Fielded through affinity groups on LinkedIn
» 61 responses (26 complete)
» Patient Adherence Solutions
» Patient Adherence, Compliance & Communication
Strategy for Pharma
» Pharmacists
» Therapy Compliance
• Patients
– High traffic area intercepts & web posts
• 33 responses
• Survey link (Polldaddy.com)
THE RESULTS ARE IN…
Conflicting Perceptions
HCPs and Patients differ on how adherent they believe patients are.
It’s simple, patients don’t adhere
because…
The team leader to tackle
adherence is…
HCPs speak out about patient
non-adherence
• Healthcare providers reasoning for why they believe
patients are not adherent 100% of the time.
– “They are not properly educated on their medications.
Doctors skip this part.”
– “They are hard headed, they diagnose and treat their selves
according to hearsay.”
– “It is socioeconomic, belief systems, and education that are
variables in this equation.”
– “I have noticed several patients that feel like giving up. They
are overwhelmed with the amount of medications that are
thrown at them on a regular basis without any non
pharmacological alternatives. Other patients have time
constraints or, being human, they just forget.”
HCPs speak with their patients.
• HCPs say the topic of adherence is brought up very
often by their patients that are taking medication.
We can all get along
• Patients & HCPs agree, the burden of taking
medication is primarily on patients.
– Burden of actually taking medication should stay on patient
but education should be provided by HCPs.
– The responsibility of adherence needs to be a multi person
effort that includes HCPs.
Team efforts drive steps towards
a solution
• Patients trust their HCPs knowledge and skills.
– General Practitioners and Specialist Physicians are most
impactful following the patient.
• Utilize this relationship to convey knowledge to patient, so
they understand their medication regime and importance.
• HCPs need to devote time to addressing patient
concerns and stressing importance of adherence.
Sources
1. Haynes, RB et al. (2001). Interventions for helping patients to follow prescriptions for medications. Cochrane
Database of Systematic Reviews, Issue
2. Haynes, RB. (1979). Determinants of compliance: The disease and the mechanics of treatment. Baltimore
MD, Johns Hopkins University Press.
3. Rand, CS. (1993). Measuring adherence with therapy for chronic disease: implications for the treatment of
heterozygous familial hypercholesterolemia. American Journal of Cardiology, 72:68D-74D.
4. Express Scripts Drug Trend Report. (2011). Nonadherence: New Insights. Retrieved February 26th, 2013,
from http://www.drugtrendreport.com/insights-and-solutions/nonadherence-new-insights/more-than-patient-
education.
5. Sacket, D. et al. (1978). Patient compliance with antihypertensive regimens. Patient Counselling & Health
Education, 11:18-21.
6. Minoff, R. (1 November, 2012). It’s Time to Put On Your Thinking CAP. PM360. Retrieved February 26th,
2013, from http://www.pm360online.com/its-time-to-put-on-your- thinking-cap/.
7. Sloss, EM et al. (2000). Selecting target conditions for quality of care improvement in vulnerable older adults.
Journal of the American Geriatrics Society, 48:363-369.
8. World Health Organization. (2003). Adherence to long-term therapies: evidence for action. WHO publications.
9. Forissier, T. (April 2012). Patient Adherence: Initiating the Journey, 2(4), 26-28.
10. Roebuck, M. C., Liberman, J. N., Gemmill-Toyama, M., & Brennan, T. A. (2011). Medication adherence
leads to lower health care use and costs despite increased drug spending. Health Affairs, 30(1), 91-9. Retrieved
from http://search.proquest.com/docview/847269644?accountid=29001
11. Viswanathan M. et al. (December 2012). Interventions to Improve Adherence to Self-administered
Medications for Chronic Diseases in the United States: A Systematic Review. Annals of Internal
Medicine.;157(11):785-795.
12. Martin, L., et al. (1 September, 2005). The Challenge of Patient Adherence; 1(3): 189–199. Clinical Risk
Management. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1661624/citedby/.
Questions or Concerns?

Weitere ähnliche Inhalte

Was ist angesagt?

Power Point Psy 492
Power Point Psy 492Power Point Psy 492
Power Point Psy 492
jamescox1
 
Factors that Influence Adherence to HAART - Naicker MH
Factors that Influence Adherence to HAART - Naicker MHFactors that Influence Adherence to HAART - Naicker MH
Factors that Influence Adherence to HAART - Naicker MH
michaela naicker
 
Antiretroviral Medication Adherence
Antiretroviral Medication AdherenceAntiretroviral Medication Adherence
Antiretroviral Medication Adherence
CDC NPIN
 
Conducting behavioral-intervention-research-rural-communities-nhc-16-101
Conducting behavioral-intervention-research-rural-communities-nhc-16-101Conducting behavioral-intervention-research-rural-communities-nhc-16-101
Conducting behavioral-intervention-research-rural-communities-nhc-16-101
dynajolly
 
Patient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and consPatient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and cons
PM Society
 
Medication Adherence in America reportcard full by National Community Pharmac...
Medication Adherence in America reportcard full by National Community Pharmac...Medication Adherence in America reportcard full by National Community Pharmac...
Medication Adherence in America reportcard full by National Community Pharmac...
Fran Maciel
 
Comparative effectiveness analysis and quality of life
Comparative effectiveness analysis and quality of lifeComparative effectiveness analysis and quality of life
Comparative effectiveness analysis and quality of life
elamar129
 
Comparative effectiveness analysis and quality of life(2)
Comparative effectiveness analysis and quality of life(2)Comparative effectiveness analysis and quality of life(2)
Comparative effectiveness analysis and quality of life(2)
elamar129
 
Comparative effectiveness analysis and quality of life
Comparative effectiveness analysis and quality of lifeComparative effectiveness analysis and quality of life
Comparative effectiveness analysis and quality of life
elamar129
 

Was ist angesagt? (20)

Lecture 16: Patient Compliance-Dr.Naif
Lecture 16: Patient Compliance-Dr.Naif Lecture 16: Patient Compliance-Dr.Naif
Lecture 16: Patient Compliance-Dr.Naif
 
Power Point Psy 492
Power Point Psy 492Power Point Psy 492
Power Point Psy 492
 
Factors that Influence Adherence to HAART - Naicker MH
Factors that Influence Adherence to HAART - Naicker MHFactors that Influence Adherence to HAART - Naicker MH
Factors that Influence Adherence to HAART - Naicker MH
 
Antiretroviral Medication Adherence
Antiretroviral Medication AdherenceAntiretroviral Medication Adherence
Antiretroviral Medication Adherence
 
Factors associated to adherence to DR-TB treatment in Georgia, Policy Brief (...
Factors associated to adherence to DR-TB treatment in Georgia, Policy Brief (...Factors associated to adherence to DR-TB treatment in Georgia, Policy Brief (...
Factors associated to adherence to DR-TB treatment in Georgia, Policy Brief (...
 
Center for Health Equity Research and Promotion
Center for Health Equity Research and PromotionCenter for Health Equity Research and Promotion
Center for Health Equity Research and Promotion
 
Novel Predictors of Medicaiton of Asherence Among Veterans 4.2.08
Novel Predictors of Medicaiton of Asherence Among Veterans 4.2.08Novel Predictors of Medicaiton of Asherence Among Veterans 4.2.08
Novel Predictors of Medicaiton of Asherence Among Veterans 4.2.08
 
Conducting behavioral-intervention-research-rural-communities-nhc-16-101
Conducting behavioral-intervention-research-rural-communities-nhc-16-101Conducting behavioral-intervention-research-rural-communities-nhc-16-101
Conducting behavioral-intervention-research-rural-communities-nhc-16-101
 
Navigator_Jessica
Navigator_JessicaNavigator_Jessica
Navigator_Jessica
 
Patient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and consPatient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and cons
 
Influence of medicare formulary restrictions on evidence based prescribing pr...
Influence of medicare formulary restrictions on evidence based prescribing pr...Influence of medicare formulary restrictions on evidence based prescribing pr...
Influence of medicare formulary restrictions on evidence based prescribing pr...
 
Canmat and-isbd-bipolar-disorder-guidelines-2013-update-src-4-14-17-cmmc...
Canmat and-isbd-bipolar-disorder-guidelines-2013-update-src-4-14-17-cmmc...Canmat and-isbd-bipolar-disorder-guidelines-2013-update-src-4-14-17-cmmc...
Canmat and-isbd-bipolar-disorder-guidelines-2013-update-src-4-14-17-cmmc...
 
Medication Adherence in America reportcard full by National Community Pharmac...
Medication Adherence in America reportcard full by National Community Pharmac...Medication Adherence in America reportcard full by National Community Pharmac...
Medication Adherence in America reportcard full by National Community Pharmac...
 
Adherence to Medication_v3
Adherence to Medication_v3Adherence to Medication_v3
Adherence to Medication_v3
 
Comparative effectiveness analysis and quality of life
Comparative effectiveness analysis and quality of lifeComparative effectiveness analysis and quality of life
Comparative effectiveness analysis and quality of life
 
Comparative effectiveness analysis and quality of life(2)
Comparative effectiveness analysis and quality of life(2)Comparative effectiveness analysis and quality of life(2)
Comparative effectiveness analysis and quality of life(2)
 
Comparative effectiveness analysis and quality of life
Comparative effectiveness analysis and quality of lifeComparative effectiveness analysis and quality of life
Comparative effectiveness analysis and quality of life
 
Medication Adherence in the Real World
Medication Adherence in the Real WorldMedication Adherence in the Real World
Medication Adherence in the Real World
 
CANMAT BIPOLAR
CANMAT BIPOLARCANMAT BIPOLAR
CANMAT BIPOLAR
 
Capella university improving quality of care and patient safety assignment ...
Capella university  improving quality of care and patient safety assignment  ...Capella university  improving quality of care and patient safety assignment  ...
Capella university improving quality of care and patient safety assignment ...
 

Andere mochten auch

Mathayas-Dissertation Defense
Mathayas-Dissertation DefenseMathayas-Dissertation Defense
Mathayas-Dissertation Defense
Sabeena Mathayas
 
Multidisciplinary analysis and optimization under uncertainty
Multidisciplinary analysis and optimization under uncertaintyMultidisciplinary analysis and optimization under uncertainty
Multidisciplinary analysis and optimization under uncertainty
Chen Liang
 
Participatory drumming and oral language articulation
Participatory drumming and oral language articulationParticipatory drumming and oral language articulation
Participatory drumming and oral language articulation
mlespier0859
 
Ed s turner iii oral defense presentation - 18 feb 10
Ed s  turner iii   oral defense presentation - 18 feb 10Ed s  turner iii   oral defense presentation - 18 feb 10
Ed s turner iii oral defense presentation - 18 feb 10
Dr. Ed S. Turner III
 
Dissertation Oral Defense
Dissertation Oral DefenseDissertation Oral Defense
Dissertation Oral Defense
Stacey Gonzales
 

Andere mochten auch (20)

Shajaira Lopez Dissertation Defense
Shajaira Lopez Dissertation DefenseShajaira Lopez Dissertation Defense
Shajaira Lopez Dissertation Defense
 
DiDomenica slides (4-12-15)
DiDomenica slides (4-12-15)DiDomenica slides (4-12-15)
DiDomenica slides (4-12-15)
 
Mathayas-Dissertation Defense
Mathayas-Dissertation DefenseMathayas-Dissertation Defense
Mathayas-Dissertation Defense
 
Oral graduate thesis defense (September 14, 2011, Guelph, Ontario).
Oral graduate thesis defense (September 14, 2011, Guelph, Ontario).Oral graduate thesis defense (September 14, 2011, Guelph, Ontario).
Oral graduate thesis defense (September 14, 2011, Guelph, Ontario).
 
PhD Defense
PhD DefensePhD Defense
PhD Defense
 
Doctoral Defense: Hany SalahEldeen
Doctoral Defense: Hany SalahEldeenDoctoral Defense: Hany SalahEldeen
Doctoral Defense: Hany SalahEldeen
 
Part 2: Business Leaders Marketing to Bottom of the Pyramid Consumers in Nigeria
Part 2: Business Leaders Marketing to Bottom of the Pyramid Consumers in NigeriaPart 2: Business Leaders Marketing to Bottom of the Pyramid Consumers in Nigeria
Part 2: Business Leaders Marketing to Bottom of the Pyramid Consumers in Nigeria
 
Multidisciplinary analysis and optimization under uncertainty
Multidisciplinary analysis and optimization under uncertaintyMultidisciplinary analysis and optimization under uncertainty
Multidisciplinary analysis and optimization under uncertainty
 
Parallel Rule Generation For Efficient Classification System
Parallel Rule Generation For Efficient Classification SystemParallel Rule Generation For Efficient Classification System
Parallel Rule Generation For Efficient Classification System
 
CSSE 2016 University of Calgary - Slides
CSSE 2016 University of Calgary - SlidesCSSE 2016 University of Calgary - Slides
CSSE 2016 University of Calgary - Slides
 
[Bảo vệ khóa luận] Dissertation defense
[Bảo vệ khóa luận] Dissertation defense[Bảo vệ khóa luận] Dissertation defense
[Bảo vệ khóa luận] Dissertation defense
 
Gary Broils, D.B.A. - Dissertation Defense: Virtual Teaming and Collaboration...
Gary Broils, D.B.A. - Dissertation Defense: Virtual Teaming and Collaboration...Gary Broils, D.B.A. - Dissertation Defense: Virtual Teaming and Collaboration...
Gary Broils, D.B.A. - Dissertation Defense: Virtual Teaming and Collaboration...
 
Unsupervised Partial Parsing: Thesis defense
Unsupervised Partial Parsing: Thesis defenseUnsupervised Partial Parsing: Thesis defense
Unsupervised Partial Parsing: Thesis defense
 
Participatory drumming and oral language articulation
Participatory drumming and oral language articulationParticipatory drumming and oral language articulation
Participatory drumming and oral language articulation
 
Dissertation proposal defense slideshow; phenomenology, qualitative
Dissertation proposal defense slideshow; phenomenology, qualitativeDissertation proposal defense slideshow; phenomenology, qualitative
Dissertation proposal defense slideshow; phenomenology, qualitative
 
Ed s turner iii oral defense presentation - 18 feb 10
Ed s  turner iii   oral defense presentation - 18 feb 10Ed s  turner iii   oral defense presentation - 18 feb 10
Ed s turner iii oral defense presentation - 18 feb 10
 
Dissertation Oral Defense
Dissertation Oral DefenseDissertation Oral Defense
Dissertation Oral Defense
 
defense_2
defense_2defense_2
defense_2
 
Example Dissertation Proposal Defense Power Point Slide
Example Dissertation Proposal Defense Power Point SlideExample Dissertation Proposal Defense Power Point Slide
Example Dissertation Proposal Defense Power Point Slide
 
DOCTORAL RESEARCH Dissertation Defense 120908
DOCTORAL RESEARCH Dissertation Defense 120908DOCTORAL RESEARCH Dissertation Defense 120908
DOCTORAL RESEARCH Dissertation Defense 120908
 

Ähnlich wie Rebecca Ruggear Senior Thesis 2013

More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims DataMore Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
M. Christopher Roebuck
 
Medication Adherence-DBediako
Medication Adherence-DBediakoMedication Adherence-DBediako
Medication Adherence-DBediako
dannbetts
 
Medication Non Adherence X
Medication Non Adherence XMedication Non Adherence X
Medication Non Adherence X
David Donohue
 
Improving Medication Adherence among Type II Home Healthcare D
Improving Medication Adherence among Type II Home Healthcare DImproving Medication Adherence among Type II Home Healthcare D
Improving Medication Adherence among Type II Home Healthcare D
MalikPinckney86
 
Running head STRATEGIC PLAN FOR CHANGE1STRATEGIC PLAN FOR.docx
Running head STRATEGIC PLAN FOR CHANGE1STRATEGIC PLAN FOR.docxRunning head STRATEGIC PLAN FOR CHANGE1STRATEGIC PLAN FOR.docx
Running head STRATEGIC PLAN FOR CHANGE1STRATEGIC PLAN FOR.docx
toltonkendal
 
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
Tanisha Davis
 

Ähnlich wie Rebecca Ruggear Senior Thesis 2013 (20)

MTM
MTMMTM
MTM
 
Medication adherence-01ccd 2
Medication adherence-01ccd 2Medication adherence-01ccd 2
Medication adherence-01ccd 2
 
Physician Dispensing
Physician DispensingPhysician Dispensing
Physician Dispensing
 
Team Lift: Predicting Medication Adherence
Team Lift: Predicting Medication AdherenceTeam Lift: Predicting Medication Adherence
Team Lift: Predicting Medication Adherence
 
teamLift-ppt-v2
teamLift-ppt-v2teamLift-ppt-v2
teamLift-ppt-v2
 
Pharmacoeconomics & drug compliance
Pharmacoeconomics & drug compliance Pharmacoeconomics & drug compliance
Pharmacoeconomics & drug compliance
 
teamLift-ppt-v1
teamLift-ppt-v1teamLift-ppt-v1
teamLift-ppt-v1
 
Compliance, concordance and empowerment in patients with type two diabetes me...
Compliance, concordance and empowerment in patients with type two diabetes me...Compliance, concordance and empowerment in patients with type two diabetes me...
Compliance, concordance and empowerment in patients with type two diabetes me...
 
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims DataMore Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
 
Physician Dispensing Services
Physician Dispensing ServicesPhysician Dispensing Services
Physician Dispensing Services
 
Medication Adherence-DBediako
Medication Adherence-DBediakoMedication Adherence-DBediako
Medication Adherence-DBediako
 
Medication Non Adherence X
Medication Non Adherence XMedication Non Adherence X
Medication Non Adherence X
 
Medication Adherence.pptx
Medication Adherence.pptxMedication Adherence.pptx
Medication Adherence.pptx
 
Medication Safety
Medication SafetyMedication Safety
Medication Safety
 
ckd jnl-1.pptx
ckd jnl-1.pptxckd jnl-1.pptx
ckd jnl-1.pptx
 
PatientBillofRights
PatientBillofRightsPatientBillofRights
PatientBillofRights
 
Improving Medication Adherence among Type II Home Healthcare D
Improving Medication Adherence among Type II Home Healthcare DImproving Medication Adherence among Type II Home Healthcare D
Improving Medication Adherence among Type II Home Healthcare D
 
Running head STRATEGIC PLAN FOR CHANGE1STRATEGIC PLAN FOR.docx
Running head STRATEGIC PLAN FOR CHANGE1STRATEGIC PLAN FOR.docxRunning head STRATEGIC PLAN FOR CHANGE1STRATEGIC PLAN FOR.docx
Running head STRATEGIC PLAN FOR CHANGE1STRATEGIC PLAN FOR.docx
 
Adherance
AdheranceAdherance
Adherance
 
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
Utilizing Care Management Nurses to Improve Transitions in Care in the Oupati...
 

Rebecca Ruggear Senior Thesis 2013

  • 1. Rebecca Ruggear Thursday, April 4, 2013 PB 449 Senior Seminar Oral Defense of Thesis
  • 2. Thesis Statement • In order to affect better patient outcomes, the burden of adherence needs to shift away from solely the patient to other stakeholders such as physicians and pharmacists.
  • 3. What is adherence? • Adherence is “the extent to which a person’s behavior – taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider.”1,2 • The reason this responsibility is left to the patients is because, “it’s easier to blame patients and hold onto the simplistic view that cost is the key drive, rather than to understand the underlying symptoms that can lead to the right interventions at the right time to increase adherence.”6 1. Haynes, RB. (1979). Determinants of compliance: The disease and the mechanics of treatment. Baltimore MD, Johns Hopkins University Press. 2. Rand, CS. (1993). Measuring adherence with therapy for chronic disease: implications for the treatment of heterozygous familial hypercholesterolemia. American Journal of Cardiology, 72:68D-74D.
  • 4. Another look at responsibility • ”A significant barrier to effective medical treatment is the patient's failure to follow the recommendations of his or her physician or other healthcare provider.”12 • “Patients' health literacy is central to their ability to adhere. ”12 12. . Martin, L., et al. (1 September, 2005). The Challenge of Patient Adherence; 1(3): 189–199. Clinical Risk Management. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1661624/citedby/.
  • 5. Why are patients non-adherent? • The five main reasons for non-adherence include9: – Negative side effects – Perceived under-performance of the product – Complexity of the treatment regime – No improvement noticed by patient – Cost 9. Forissier, T. (April 2012). Patient Adherence: Initiating the Journey, 2(4), 26-28.
  • 6. Does adherence matter? Express Scripts Drug Trend Report. (2011). Nonadherence: New Insights. Retrieved February 26th, 2013, from http://www.drugtrendreport.com/insights-and-solutions/nonadherence-new- insights/more-than-patient-education.
  • 7. What are the numbers? • Adherence to long-term therapy for chronic illnesses in developed countries averages 50%.1,5 – Rates are even lower in developing countries. • Non-adherence costs the U.S. health care system between $100 billion and $289 billion annually.11 • Estimates of hospitalization costs due to medication non- adherence are as high as $13.35 billion annually in the US alone.11 1.Haynes, RB et al. (2001). Interventions for helping patients to follow prescriptions for medications. Cochrane Database of Systematic Reviews, Issue 5. Sacket, D. et al. (1978). Patient compliance with antihypertensive regimens. Patient Counselling & Health Education, 11:18-21. 11. Viswanathan, M. et al. (December 2012). Interventions to Improve Adherence to Self-administered Medications for Chronic Diseases in the United States: A Systematic Review. Annals of Internal Medicine.;157(11):785-795.
  • 8. How does being adherent save money? • Higher rates of adherence contribute to economic benefits8 – “Direct savings caused by reduced use of sophisticated and expensive health services needed in cases of disease exacerbation, crisis or relapse.”8 – “Indirect savings may be attributable to enhancement or preservation of, quality of life and the social and vocational roles of the patients.”8 – Reduction in the numbers of patients being hospitalized, days in the hospital and outpatient visits.7 • Cost to savings ratio of approx. 1:10 over a 3 year study 7. Sloss, EM et al. (2000). Selecting target conditions for quality of care improvement in vulnerable older adults. Journal of the American Geriatrics Society, 48:363-369. 8. World Health Organization. (2003). Adherence to long-term therapies: evidence for action. WHO publications.
  • 9. Specific savings • Pharmacy costs for all prescriptions filled, ranged from $2,867 to $3,780 per patient per year.10 • Annual medical spending was significantly lower for adherent patients. • Savings are mainly through reduced inpatient hospital days and emergency department visits. 10. Roebuck, M. C., Liberman, J. N., Gemmill- Toyama, M., & Brennan, T. A. (2011). Medication adherence leads to lower health care use and costs despite increased drug spending. Health Affairs, 30(1), 91-9. Retrieved from http://search.proquest.com/docview/847269644?acc ountid=29001 Disease state Total health care costs Average annual medical spending Annual per person savings Congestive heart failure $39,076 $8,881 $7,823 Hypertension $14,813 $4,337 $3,908 Diabetes $17,955 $4,413 $3,756 Dyslipidemia $12,688 $1,860 $1,258
  • 10. Positive impact on patient health “Increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatments.”3 3. Haynes, RB et al. (2001). Interventions for helping patients to follow prescriptions for medications. Cochrane Database of Systematic Reviews, Issue 1.
  • 11. Tackling The Problem • Objectives – Determine general attitudes on whose responsibility it is for patient adherence. – Determine reasons for non-adherent behavior. – Research tactics and effectiveness of those tactics to increase patient adherence. • Subjects – Healthcare Professionals • Pharmacists • General Practitioners • Specialist Physicians • Nurses/Physician Assistants – Patients (M/W aged 30+)
  • 12. Where do we find them? • Healthcare professionals • Web-based survey (Surveymonkey.com) – Fielded through affinity groups on LinkedIn » 61 responses (26 complete) » Patient Adherence Solutions » Patient Adherence, Compliance & Communication Strategy for Pharma » Pharmacists » Therapy Compliance • Patients – High traffic area intercepts & web posts • 33 responses • Survey link (Polldaddy.com)
  • 14. Conflicting Perceptions HCPs and Patients differ on how adherent they believe patients are.
  • 15. It’s simple, patients don’t adhere because…
  • 16. The team leader to tackle adherence is…
  • 17. HCPs speak out about patient non-adherence • Healthcare providers reasoning for why they believe patients are not adherent 100% of the time. – “They are not properly educated on their medications. Doctors skip this part.” – “They are hard headed, they diagnose and treat their selves according to hearsay.” – “It is socioeconomic, belief systems, and education that are variables in this equation.” – “I have noticed several patients that feel like giving up. They are overwhelmed with the amount of medications that are thrown at them on a regular basis without any non pharmacological alternatives. Other patients have time constraints or, being human, they just forget.”
  • 18. HCPs speak with their patients. • HCPs say the topic of adherence is brought up very often by their patients that are taking medication.
  • 19. We can all get along • Patients & HCPs agree, the burden of taking medication is primarily on patients. – Burden of actually taking medication should stay on patient but education should be provided by HCPs. – The responsibility of adherence needs to be a multi person effort that includes HCPs.
  • 20. Team efforts drive steps towards a solution • Patients trust their HCPs knowledge and skills. – General Practitioners and Specialist Physicians are most impactful following the patient. • Utilize this relationship to convey knowledge to patient, so they understand their medication regime and importance. • HCPs need to devote time to addressing patient concerns and stressing importance of adherence.
  • 21. Sources 1. Haynes, RB et al. (2001). Interventions for helping patients to follow prescriptions for medications. Cochrane Database of Systematic Reviews, Issue 2. Haynes, RB. (1979). Determinants of compliance: The disease and the mechanics of treatment. Baltimore MD, Johns Hopkins University Press. 3. Rand, CS. (1993). Measuring adherence with therapy for chronic disease: implications for the treatment of heterozygous familial hypercholesterolemia. American Journal of Cardiology, 72:68D-74D. 4. Express Scripts Drug Trend Report. (2011). Nonadherence: New Insights. Retrieved February 26th, 2013, from http://www.drugtrendreport.com/insights-and-solutions/nonadherence-new-insights/more-than-patient- education. 5. Sacket, D. et al. (1978). Patient compliance with antihypertensive regimens. Patient Counselling & Health Education, 11:18-21. 6. Minoff, R. (1 November, 2012). It’s Time to Put On Your Thinking CAP. PM360. Retrieved February 26th, 2013, from http://www.pm360online.com/its-time-to-put-on-your- thinking-cap/. 7. Sloss, EM et al. (2000). Selecting target conditions for quality of care improvement in vulnerable older adults. Journal of the American Geriatrics Society, 48:363-369. 8. World Health Organization. (2003). Adherence to long-term therapies: evidence for action. WHO publications. 9. Forissier, T. (April 2012). Patient Adherence: Initiating the Journey, 2(4), 26-28. 10. Roebuck, M. C., Liberman, J. N., Gemmill-Toyama, M., & Brennan, T. A. (2011). Medication adherence leads to lower health care use and costs despite increased drug spending. Health Affairs, 30(1), 91-9. Retrieved from http://search.proquest.com/docview/847269644?accountid=29001 11. Viswanathan M. et al. (December 2012). Interventions to Improve Adherence to Self-administered Medications for Chronic Diseases in the United States: A Systematic Review. Annals of Internal Medicine.;157(11):785-795. 12. Martin, L., et al. (1 September, 2005). The Challenge of Patient Adherence; 1(3): 189–199. Clinical Risk Management. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1661624/citedby/.

Hinweis der Redaktion

  1. Total healthcare costs per patient per year
  2. HCPs believe patients are 75-100 adherent only about 9% of the time.
  3. Likert scale